(VIANEWS) – Shares of SARTORIUS STED BIO (CAC 40: DIM.PA) slid by a staggering 12.95% to €240.70 at 14:08 EST on Monday, after five sequential sessions in a row of gains. CAC 40 is sliding 0.5% to €7,351.67, following the last session’s upward trend. This seems, at the moment, a somewhat bearish trend exchanging session today.
SARTORIUS STED BIO’s last close was €276.50, 30.88% under its 52-week high of €400.00.
About SARTORIUS STED BIO
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; batch and intensified chromatography systems for smaller molecules applications, such as oligonucleotides, peptides, and insulin; and recombinant albumin based solutions. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of medications, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.
Earnings Per Share
As for profitability, SARTORIUS STED BIO has a trailing twelve months EPS of €7.8.
PE Ratio
SARTORIUS STED BIO has a trailing twelve months price to earnings ratio of 30.86. Meaning, the purchaser of the share is investing €30.86 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.37%.
More news about SARTORIUS STED BIO (DIM.PA).
